Jeffrey Seidler

Jeffrey Seidler is currently engaged in Finance, Operations, and Development at Akoya Biosciences, Inc. since 2024. Prior to this role, Jeffrey held a similar position at Specific Diagnostics from 2021 to 2024, contributing to the company’s sale to bioMerieux for $425 million. Jeffrey's experience includes a brief tenure at GenMark Diagnostics in 2021, where efforts culminated in the company being sold to Roche for $1.8 billion. Previous roles also encompass Finance and Development at DISH Network from 2018 to 2021, marketing with the San Diego Padres in 2016-2017, and an analyst position at Bois Capital (2015-2016) focusing on Technology, Media, and Telecom. Academic credentials include a Master’s and Bachelor’s degree in Finance, both obtained from the University of San Diego.